Kepler Capital Markets set a €84.00 ($97.67) target price on Bayer (FRA:BAYN) in a report released on Monday morning. The firm currently has a buy rating on the healthcare company’s stock.

Several other research firms have also recently weighed in on BAYN. Sanford C. Bernstein set a €120.00 ($139.53) price objective on Bayer and gave the stock a buy rating in a research report on Monday, June 4th. Jefferies Financial Group set a €123.00 ($143.02) target price on Bayer and gave the stock a buy rating in a report on Monday, June 4th. UBS Group set a €130.00 ($151.16) target price on Bayer and gave the stock a buy rating in a report on Friday, June 1st. Warburg Research set a €118.00 ($137.21) target price on Bayer and gave the stock a neutral rating in a report on Monday, June 4th. Finally, equinet set a €118.00 ($137.21) target price on Bayer and gave the stock a buy rating in a report on Monday, June 4th. Seven equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. The stock has an average rating of Buy and a consensus price target of €99.20 ($115.35).

BAYN stock opened at €77.65 ($90.29) on Monday. Bayer has a fifty-two week low of €91.58 ($106.49) and a fifty-two week high of €123.82 ($143.98).

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Recommended Story: What is Considered a Good Return on Equity (ROE)?

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.